文献速递艾滋病与性传播感染

衰弱与中老年HIV阳性及阴性参与者死亡和突发合并症相关

Frailty Is Associated With Mortality and Incident Comorbidity Among Middle-Aged Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Participants.
PubMed 文献 · J Infect Dis · 2020-01-01

AGEhIV队列研究纳入598例HIV阳性和550例可比的HIV阴性≥45岁参与者,随访6年评估全因死亡、4年评估突发合并症。基线7.5%为衰弱,衰弱者死亡率25.7/1000人年,全调整后衰弱与死亡(HR 4.6)和突发合并症(OR 1.9)独立相关,且与HIV状态无交互作用。

要点

  • 衰弱是死亡和突发合并症的强预测因素,独立于HIV状态和其他风险因素。
  • 基线衰弱者全因死亡率为25.7/1000人年,显著高于衰弱前期和健壮者。
  • 衰弱与HIV状态无交互作用,提示HIV阳性和阴性者中衰弱影响相似。

核心结论

  • 衰弱是全因死亡和突发合并症的强预测因素,独立于其他风险因素。
  • 衰弱与HIV状态的交互作用在所有分析中均未观察到。

研究设计与样本

  • AGEhIV队列研究,纳入598例HIV阳性和550例可比的HIV阴性≥45岁参与者。
  • 随访6年评估全因死亡,随访4年评估突发合并症。
  • 衰弱包括5个维度:体重下降、低体力活动、疲乏、握力下降和步速减慢;≥3项为衰弱,1-2项为衰弱前期,0项为健壮。
  • 采用多变量Cox和logistic回归模型评估衰弱与结局的独立关系,调整HIV感染和传统风险因素。

主要发现

  • 基线时7.5%(n=86)参与者为衰弱。
  • 随访期间38例参与者死亡。
  • 衰弱者死亡率为25.7/1000人年(95%CI 14.2-46.4),衰弱前期为7.2/1000人年(95%CI 4.7-11.2),健壮者为2.3/1000人年(95%CI 1.1-4.9)。
  • 全调整分析中,衰弱与死亡强相关(HR 4.6,95%CI 1.7-12.5),与突发合并症相关(OR 1.9,95%CI 1.1-3.1)。

临床怎么用

  • 在≥45岁HIV阳性和阴性人群中,应评估衰弱以识别死亡和合并症高风险个体。
  • 衰弱评估可作为风险分层工具,独立于HIV状态和传统风险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty is associated with mortality and morbidity in the general geriatric population, but less is known about its impact among the aging but generally younger population with human immunodeficiency virus (HIV). METHODS: The impact of frailty on all-cause mortality during 6 years of follow-up and incident comorbidity during 4 years of follow-up was assessed among 598 HIV-positive and 550 comparable HIV-negative participants aged ≥ 45 years of the AGEhIV Cohort Study. Frailty encompasses 5 domains; weight loss, low physical activity, exhaustion, decreased grip strength, and slow gait speed. Presence of ≥ 3 denotes frailty, 1-2 prefrailty, and 0 robust. Multivariable Cox and logistic regression models were used to assess the independent relationships of frailty with both outcomes, adjusting for HIV infection and traditional risk factors. RESULTS: At baseline, 7.5% (n = 86) of participants were frail. During follow-up, 38 participants died. Mortality rate was significantly higher among frail participants: 25.7/1000 person-years of follow-up (PYFU) (95% confidence interval [CI], 14.2-46.4) compared with prefrail (7.2/1000 PYFU [95% CI, 4.7-11.2]) and robust (2.3/1000 PYFU [95% CI, 1.1-4.9]). In fully adjusted analyses, frailty remained strongly associated with death (hazard ratio, 4.6 [95% CI, 1.7-12.5]) and incident comorbidity (odds ratio, 1.9 [95% CI, 1.1-3.1]). No interactions were observed between frailty and HIV status in all analyses. CONCLUSIONS: Frailty is a strong predictor of both mortality and incident comorbidity independent from other risk factors. CLINICAL TRIALS REGISTRATION: NCT01466582.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Verheij E, Kirk GD, Wit FW, et al. Frailty Is Associated With Mortality and Incident Comorbidity Among Middle-Aged Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Participants. J Infect Dis. 2020. PMID: 31956893. doi:10.1093/infdis/jiaa010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。